South Big Data Hub Roundtable
Q2 Solutions Roundtable Discussion with South Big Data Hub
About This EventSouth Big Data Hub will be hosting a roundtable discussion at the Renaissance Computing Center in Chapel Hill, NC on April 13th.
Plan to join Q2 Solutions’ Victor Weigman, Director, Translational Genomics as he participates as a panelist in the discussion, “Data Science Challenges for Cancer Immunotherapy”. You can either attend in person or participate live via WebEx.
Learn more about the event and RSVP to attend in person on event website.
Director, Translational Genomics
Dr. Victor Weigman, Ph.D. is Director, Translational Genomics at Q2 Solutions, a Quintiles Quest Joint Venture, leading the group with a goal of continued facilitation of pre-clinical drug development through biomarker identification. Ongoing research revolves around the genomic profiling of solid tumors from both DNA and RNA approaches including the development of robust assays that can be leveraged as laboratory developed tests.
Dr. Weigman brings more than 10 years of biomarker discovery research with genomics, with a majority of them dedicated to Expression Analysis (EA), a Q2 Solutions Company. He has published 14 papers on biomarker identification and assay development and has contributed to the development and launch of several genomic CLIA Assays. Additionally, Dr. Weigman is involved in pharma partnerships for clinical trial development using genomic profiling technologies.
Dr. Weigman obtained his Ph.D. at the University of North Carolina in Biology and Bioinformatics within the Lineberger Comprehensive Cancer Center.
Updated as of September 2018.